Theriva Biologics TOVX
NYSE TOVX
$0.23 +0.02 (+9.52%)
At close: Sep 30, 2026 · 4:00 PM EDT

Theriva Biologics (TOVX) Revenue (2010 - 2026)

Updated

Theriva Biologics (TOVX) reported Revenue of $300,000 for Q1 2026.

Analysis

Theriva Biologics (TOVX) Revenue (2010 - 2026) Analysis & Trends

For FY2010, Theriva Biologics posted Revenue of $2.61 million.

  • The Q1 2026 figure ranks as the highest quarterly Revenue since Q2 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Theriva Biologics 10.56 Mn 10.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 300,000.00
Dec 31, 2011 -972,121.00
Sep 30, 2011 293,421.00
Jun 30, 2011 355,562.00
Dec 31, 2010 69,175.00
Sep 30, 2010 289,898.00
Jun 30, 2010 2.19 Mn
API Access

Theriva Biologics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=TOVX&period=max&api_key=YOUR_API_KEY